Suchergebnisse - "Ordóñez, José Luis"

PubPharm (58)

1

Renal Sympathetic Hyperactivity in Diabetes Is Modulated by 5-HT1D Receptor Activation via NO Pathway

enthalten in: International journal of molecular sciences | 2023

von Fernández-González, J. | García-Pedraza, J. | Ordóñez, J. | +4

2

CRISPR/Cas9-directed Gene Trap Constitutes a Selection System for Corrected BCR/ABL Leukemic Cells in CML

enthalten in: Preprints.org | 2022

von Vuelta, E. | Ordoñez, J. | Sanz, D. | +5

3

CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer : Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia

enthalten in: The CRISPR journal | 2021

von Vuelta, E. | Ordoñez, J. | Alonso-Pérez, V. | +10

4

Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression

enthalten in: Blood cancer journal | 2021

von Quijada-Álamo, M. | Hernández-Sánchez, M. | Rodríguez-Vicente, A. | +15

5

Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia

enthalten in: Clinical and translational medicine | 2021

von Quijada-Álamo, M. | Pérez-Carretero, C. | Hernández-Sánchez, M. | +16

6

Changes in the Organosulfur and Polyphenol Compound Profiles of Black and Fresh Onion during Simulated Gastrointestinal Digestion

enthalten in: Foods (Basel, Switzerland) | 2021

von Moreno-Ortega, A. | Ordóñez, J. | Moreno-Rojas, R. | +2

7

A phenolic-rich extract from Ugni molinae berries reduces abnormal protein aggregation in a cellular model of Huntington's disease

enthalten in: PloS one | 2021

von Pérez-Arancibia, R. | Ordoñez, J. | Rivas, A. | +9

8

Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia

enthalten in: Clinical and Translational Medicine | 2021

von Quijada‐Álamo, M. | Pérez‐Carretero, C. | Hernández‐Sánchez, M. | +16

9

Bioaccessibility of Bioactive Compounds of 'Fresh Garlic' and 'Black Garlic' through In Vitro Gastrointestinal Digestion

enthalten in: Foods (Basel, Switzerland) | 2020

von Moreno-Ortega, A. | Pereira-Caro, G. | Ordóñez, J. | +3

10

CRISPR/Cas9 technology abolishes the BCR/ABL1 oncogene in chronic myeloid leukemia and restores normal hematopoiesis

enthalten in: bioRxiv.org | 2020

von Vuelta, E. | Ordoñez, J. | Alonso-Pérez, V. | +10

1
2
3
4
5
6
Nächster »
[6]